Replimune (REPL)

[jondoeuk]

The PR https://markets.businessinsider.com/news/stocks/replimune-presents-initial-clinical-data-with-rp1-that-strongly-supports-expansion-of-clinical-programs-in-melanoma-and-cutaneous-squamous-cell-carcinoma-cscc-1028673120

Poster https://ir.replimune.com/static-files/d8fe8ff4-47ce-4b49-9cea-118b347d79ae

CSCC deck https://ir.replimune.com/static-files/6055ead4-f9f7-496d-bfd5-c2e22b31bd2a

Melanoma deck https://ir.replimune.com/static-files/22e528d6-c3ae-4156-a8db-e8873d9123a4

Event deck https://ir.replimune.com/static-files/9f8d4d33-ef0a-433f-8483-bba680aae25d